TESARO Shares Outstanding 2011-2018 | TSRO

Current and historical number of shares outstanding for TESARO (TSRO) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.223B
Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.578B 11.25
Zoetis (ZTS) United States $41.332B 32.60
Grifols (GRFS) Spain $14.271B 18.50
Jazz Pharmaceuticals (JAZZ) Ireland $10.677B 17.96
Neurocrine Biosciences (NBIX) United States $9.332B 0.00
Nektar Therapeutics (NKTR) United States $8.412B 0.00
Sage Therapeutics (SAGE) United States $7.844B 0.00
Catalent (CTLT) United States $5.780B 26.92
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
United Therapeutics (UTHR) United States $5.403B 9.81
FibroGen (FGEN) United States $5.379B 0.00
Loxo Oncology (LOXO) United States $5.329B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.485B 18.38
Madrigal Pharmaceuticals (MDGL) United States $4.114B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.048B 0.00
Aerie Pharmaceuticals (AERI) United States $2.919B 0.00
Heron Therapeutics (HRTX) United States $2.806B 0.00
USANA Health Sciences (USNA) United States $2.691B 25.88
Portola Pharmaceuticals (PTLA) United States $2.628B 0.00
Endo (ENDP) Ireland $2.511B 3.42
Spectrum Pharmaceuticals (SPPI) United States $2.473B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.372B 43.82
Xencor (XNCR) United States $2.354B 0.00
Zogenix (ZGNX) United States $2.076B 0.00
PTC Therapeutics (PTCT) United States $1.698B 0.00
Corcept Therapeutics (CORT) United States $1.523B 25.42
Pacira Pharmaceuticals (PCRX) United States $1.507B 0.00
TherapeuticsMD (TXMD) United States $1.453B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.442B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.428B 0.00
Impax Laboratories (AMRX) United States $1.366B 29.35
ImmunoGen (IMGN) United States $1.326B 0.00
Radius Health (RDUS) United States $1.294B 0.00
Tricida (TCDA) United States $1.201B 0.00
Endocyte (ECYT) United States $1.188B 0.00
Esperion Therapeutics (ESPR) United States $1.155B 0.00
Flexion Therapeutics (FLXN) United States $1.024B 0.00
OptiNose (OPTN) United States $1.005B 0.00
Karyopharm Therapeutics (KPTI) United States $0.957B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.812B 0.00
GlycoMimetics (GLYC) United States $0.700B 0.00
Dova Pharmaceuticals (DOVA) United States $0.687B 0.00
Collegium Pharmaceutical (COLL) United States $0.662B 0.00
Translate Bio (TBIO) United States $0.657B 0.00
Aclaris Therapeutics (ACRS) United States $0.631B 0.00
Odonate Therapeutics (ODT) United States $0.624B 0.00
CASI Pharmaceuticals (CASI) United States $0.613B 0.00
ChemoCentryx (CCXI) United States $0.605B 42.41
BioCryst Pharmaceuticals (BCRX) United States $0.599B 0.00
Akebia Therapeutics (AKBA) United States $0.598B 0.00
Siga Technologies (SIGA) United States $0.572B 0.00
Depomed (DEPO) United States $0.520B 0.00
ArQule (ARQL) United States $0.498B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.487B 0.00
Lannett Co Inc (LCI) United States $0.487B 4.48
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.483B 0.00
Forty Seven (FTSV) United States $0.471B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.466B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.460B 0.00
ElectroCore (ECOR) United States $0.450B 0.00
Majesco Entertainment (COOL) United States $0.436B 0.00
Dermira (DERM) United States $0.421B 0.00
Mast Therapeutics (SVRA) United States $0.391B 0.00
Concert Pharmaceuticals (CNCE) United States $0.389B 0.00
Xeris Pharmaceuticals (XERS) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.338B 26.37
Achaogen (AKAO) United States $0.332B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.327B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.325B 0.00
Minerva Neurosciences (NERV) United States $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.316B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.311B 0.00
Neon Therapeutics (NTGN) United States $0.310B 0.00
Tyme Technologies (TYME) United States $0.302B 0.00
Zafgen (ZFGN) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.255B 0.00
Jounce Therapeutics (JNCE) United States $0.253B 0.00
DURECT (DRRX) United States $0.244B 0.00
Ocular Therapeutix (OCUL) United States $0.240B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.239B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.231B 0.00
ProNAi Therapeutics (SRRA) Canada $0.224B 0.00
Redhill Biopharma (RDHL) Israel $0.220B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.219B 0.00
Immune Design (IMDZ) United States $0.214B 0.00
Aratana Therapeutics (PETX) United States $0.212B 0.00
Ardelyx (ARDX) United States $0.209B 0.00
IMV INC (IMV) Canada $0.207B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.207B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.204B 0.00
Melinta Therapeutics (MLNT) United States $0.190B 0.00
ContraFect (CFRX) United States $0.180B 0.00
Neos Therapeutics (NEOS) United States $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.173B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Adherex Technologies (FENC) United States $0.170B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.159B 0.00
Opexa Therapeutics (ACER) United States $0.153B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
MEI Pharma (MEIP) United States $0.151B 0.00
Cardiome Pharma (CORV) Canada $0.141B 0.00
Molecular Templates (MTEM) United States $0.136B 0.00
CTI BioPharma (CTIC) United States $0.132B 0.00
Forward Pharma (FWP) Denmark $0.129B 0.00
Juniper Pharmaceuticals (JNP) United States $0.127B 190.83
Adamis Pharmaceuticals (ADMP) United States $0.122B 0.00
SteadyMed (STDY) Israel $0.120B 0.00
Recro Pharma (REPH) United States $0.117B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Otonomy (OTIC) United States $0.113B 0.00
Nivalis Therapeutics (ALPN) United States $0.113B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.111B 0.00
Affimed (AFMD) Germany $0.111B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
BioLineRx (BLRX) Israel $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
KalVista Pharmaceuticals (KALV) United States $0.092B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Trillium Therapeutics (TRIL) Canada $0.077B 0.00
Novan (NOVN) United States $0.077B 0.00
Natural Alternatives (NAII) United States $0.077B 9.85
KemPharm (KMPH) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.066B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.061B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.37
Capnia (SLNO) United States $0.054B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 34.67
Onconova Therapeutics (ONTX) United States $0.037B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.035B 0.00
Xenetic Biosciences (XBIO) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Dipexium Pharmaceuticals (PLXP) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Biomerica (BMRA) United States $0.034B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.031B 0.00
IsoRay (ISR) United States $0.031B 0.00
Regulus Therapeutics (RGLS) United States $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Shineco (TYHT) China $0.029B 2.49
NanoViricides (NNVC) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Cyanotech (CYAN) United States $0.023B 21.67
Aradigm (ARDM) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
Midatech Pharma (MTP) United Kingdom $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Egalet (EGLT) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Intellipharmaceutics (IPCI) Canada $0.017B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.017B 0.00
Pain Therapeutics (PTIE) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
PharmAthene (ALT) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.17
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00